Maynard Um
-
-
-
-
-
-
-
UBS Reiterates Neutral Rating on Moderna (MRNA)
-
-
-
-
-
-
-
WHO expects additional cases of hantavirus, but no wider outbreak seen
-
-
-
-
-
-
-
Moderna Is Working On Early-stage Hantavirus Vaccines - Bloomberg
-
-
-
-
-
-
-
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19
-
-
-
-
-
-
-
Moderna shares jump as settlement removes major legal overhang
-
-
-
-
-
-
-
European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influen
-
397,028 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

